{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:30:32Z","timestamp":1774125032043,"version":"3.50.1"},"reference-count":54,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003900","type":"journal-article","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T17:16:55Z","timestamp":1069435015000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease"],"prefix":"10.1002","volume":"2010","author":[{"given":"Douglas C","family":"McCrory","sequence":"first","affiliation":[{"name":"Duke University; Center for Clinical Health Policy Research; 2200 W. Main Street, Suite 220 Durham NC USA 27705"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia D","family":"Brown","sequence":"additional","affiliation":[{"name":"Brody School of Medicine; Section of Pulmonary & Critical Care Medicine; Room E-149B, Brody Medical Science Building 600 Moye Blvd Greenville North Carolina USA 27858"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,1,20]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD003900-BIB0001|cit1","first-page":"135","article-title":"Fenoterol and ipratropium in respiratory treatment of patients with chronic bronchitis","volume":"38","author":"Backman","year":"1985","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"issue":"4","key":"10.1002\/14651858.CD003900-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0196-0644(95)70260-1","article-title":"Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of chronic obstructive pulmonary disease","volume":"25","author":"Cydulka","year":"1995","journal-title":"Annals of Emergency Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003900-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1378\/chest.98.4.835","article-title":"A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD","volume":"98","author":"Karpel","year":"1990","journal-title":"Chest"},{"key":"10.1002\/14651858.CD003900-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1183\/09031936.93.01060536","article-title":"Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease","volume":"1","author":"Lloberes","year":"1988","journal-title":"European Respiratory Journal"},{"issue":"8","key":"10.1002\/14651858.CD003900-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/thx.50.8.834","article-title":"Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease","volume":"50","author":"Moayyedi","year":"1995","journal-title":"Thorax"},{"issue":"8652","key":"10.1002\/14651858.CD003900-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0140-6736(89)90126-8","article-title":"Nebulized salbutamol with and without ipratropium bromide in acute airflow obstruction","volume":"1","author":"O'Driscoll","year":"1989","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003900-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1378\/chest.98.2.295","article-title":"Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy","volume":"98","author":"Patrick","year":"1990","journal-title":"Chest"},{"key":"10.1002\/14651858.CD003900-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-9343(87)90378-0","article-title":"Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room","volume":"82","author":"Rebuck","year":"1987","journal-title":"The American Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD003900-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0196-0644(05)81472-6","article-title":"Decreased duration of emergency department treatment of chronic obstructive pulmonary disease exacerbations with the addition of ipratropium bromide to beta-agonist therapy","volume":"20","author":"Shrestha","year":"1991","journal-title":"Annals of Emergency Medicine"},{"issue":"13-14","key":"10.1002\/14651858.CD003900-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0024-3205(97)00047-7","article-title":"Discovery and development of selective M3 antagonists for clinical use","volume":"Vol 60","author":"Alabaster","year":"1997","journal-title":"Life Sciences"},{"issue":"11","key":"10.1002\/14651858.CD003900-BIB0011|cit11","first-page":"62","article-title":"Bronchodilation for COPD?","volume":"24","author":"Anonymous","year":"1992","journal-title":"Emergency Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003900-BIB0012|cit12","first-page":"119","article-title":"Combivent","volume":"32","author":"Anonymous","year":"1997","journal-title":"Hospital Formulary"},{"issue":"6","key":"10.1002\/14651858.CD003900-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1378\/chest.112.6.1514","article-title":"Routine nebulized ipratropium and albuterol together are better than either alone in COPD. The COMBIVENT Inhalation Solution Study Group","volume":"112","author":"Anonymous","year":"1997","journal-title":"Chest"},{"key":"10.1002\/14651858.CD003900-BIB0014|cit14","unstructured":"Anzueto A Kesten S Effects of tiotropium in COPD patients only treated with PRN albuterol [Abstract] American Thoracic Society 100th International Conference, May 21-26, Orlando 2004 C47, Poster F81"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD003900-BIB0015|cit15","first-page":"341s","article-title":"The effect of combined B2-agonist and anticholinergic inhaled therapy in patients with COPD [Abstract]","volume":"24","author":"Arsovki","year":"2004","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD003900-BIB0016|cit16","unstructured":"Balkinssoon RC Murphy JR Make B Safety and efficacy of albuterol vs aulbuterol\/ipratropium bromide in COPD subjects on fluticasone\/salmeterol 500\/50 [Abstract] American Thoracic Society 2005 International Conference; May 20-25; San Diego, California 2005 Poster F8"},{"issue":"4A","key":"10.1002\/14651858.CD003900-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"24A","DOI":"10.1016\/0002-9343(91)90258-Y","article-title":"Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease","volume":"91","author":"Bleecker","year":"1991","journal-title":"The American Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003900-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1378\/chest.108.3.730","article-title":"Is an anticholinergic agent superior to a beta2-agonist in improving dyspnea and exercise limitation in COPD?","volume":"108","author":"Blosser","year":"1995","journal-title":"Chest"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD003900-BIB0019|cit19","first-page":"504s","article-title":"Evaluation of bronchodiltor response to single dose tiotropium bromide [Abstract]","volume":"24","author":"Celikel","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"Suppl","key":"10.1002\/14651858.CD003900-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02718145","article-title":"The role of anticholinergic bronchodilators in adult asthma and chronic obstructive pulmonary disease","volume":"168","author":"Chapman","year":"1990","journal-title":"Lung"},{"key":"10.1002\/14651858.CD003900-BIB0021|cit21","unstructured":"de Guia T Punzal P Canizares L Sy-Naval S Salonga R Tan D Evaluation of the response of Filipino COPD patients to Tiotropium (EVEREST STUDY) [Abstract] American Thoracic Society 100th International Conference, May 21-26; Orlando 2004 Poster F78"},{"issue":"3","key":"10.1002\/14651858.CD003900-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/22953337.1984.11718997","article-title":"Effects of 40 mcg. and 400 mcg. of ipratropium bromide in obstructive lung disease","volume":"39","author":"Dejaegher","year":"1984","journal-title":"Acta Clinica Belgica"},{"issue":"6-7","key":"10.1002\/14651858.CD003900-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0024-3205(98)00588-8","article-title":"Tiotropium (spiriva(TM)): Mechanistical considerations and clinical profile in obstructive lung disease","volume":"64","author":"Disse","year":"1999","journal-title":"Life Sciences"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD003900-BIB0025|cit24","first-page":"513s","article-title":"Tiotropium reduces health resource utilization associated with COPD exacerbations [Abstract]","volume":"24","author":"Dusser","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD003900-BIB0024|cit25","first-page":"513s","article-title":"Tiotropium reduces COPD exacerbations: the MISTRAL study","volume":"24","author":"Dusser","year":"2004","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD003900-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01704700","article-title":"Comparison of one versus two bronchodilators in ventilated COPD patients","volume":"20","author":"Fernandez","year":"1994","journal-title":"Intensive Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003900-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1164\/ajrccm\/136.5.1091","article-title":"Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease. Comparison with a beta-adrenergic agent","volume":"136","author":"Gross","year":"1987","journal-title":"American Review of Respiratory Disease"},{"issue":"2","key":"10.1002\/14651858.CD003900-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2165\/00002512-199812020-00005","article-title":"Pharmacological treatment in acute exacerbations of chronic obstructive pulmonary disease","volume":"12","author":"Ikeda","year":"1998","journal-title":"Drugs & Aging"},{"key":"10.1002\/14651858.CD003900-BIB0029|cit29","unstructured":"Kalberg C Emmett A Bourne E Merchant K Knobil K Fluticasone propionate\/salmeterol provides greater relief of dyspnea than Ipratropium\/Albuterol in patients with COPD [Abstract] American Thoracic Society 100th International Conference, May 21-26; Orlando 2004 Poster 528"},{"issue":"8","key":"10.1002\/14651858.CD003900-BIB0030|cit30","first-page":"815","article-title":"Responses to inhaled bronchodilator in patients with acute airflow obstruction","volume":"40","author":"Limauro","year":"1995","journal-title":"Respiratory Care"},{"issue":"1","key":"10.1002\/14651858.CD003900-BIB0031|cit31","first-page":"114","article-title":"Inhalational anticholinergic versus inhaled beta-mimetic drugs in COPD","volume":"40","author":"Lode","year":"1999","journal-title":"Internist"},{"issue":"9126","key":"10.1002\/14651858.CD003900-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(97)11081-9","article-title":"Chronic obstructive pulmonary disease","volume":"352","author":"Madison","year":"1998","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD003900-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0954-6111(96)90178-X","article-title":"A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease","volume":"90","author":"Matera","year":"1996","journal-title":"Respiratory Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003900-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0300-2896(15)30274-X","article-title":"Treatment of chronic bronchitis and chronic pulmonary obstructive disease in primary care","volume":"35","author":"Miravitlles","year":"1999","journal-title":"Archivos de bronchopneumologia"},{"issue":"3","key":"10.1002\/14651858.CD003900-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0954-6111(99)90004-5","article-title":"Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group","volume":"93","author":"Miravitlles","year":"1999","journal-title":"Respiratory Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003900-BIB0036|cit36","first-page":"257","article-title":"Dosage of drugs in combined nebulisation therapy of patients with chronic obstructive pulmonary disease (COPD)","volume":"57","author":"Musil","year":"1998","journal-title":"Studia Pneumologica et Phtiseologica"},{"issue":"7","key":"10.1002\/14651858.CD003900-BIB0037|cit37","first-page":"415","article-title":"What is the adequate dose in combined inhalation treatment of patients with exacerbations of chronic obstructive pulmonary disease?","volume":"44","author":"Musil","year":"1998","journal-title":"Vnitrni Lekarstvi"},{"issue":"1","key":"10.1002\/14651858.CD003900-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1378\/chest.128.1.48","article-title":"A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol in acute exacerbations of COPD","volume":"128","author":"Nair","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD003900-BIB0039|cit39","first-page":"38","article-title":"Effects of oxitropium bromide on exercise and lung function in patients with pulmonary emphysema","volume":"35","author":"Nakanishi","year":"1997","journal-title":"Japanese Journal of Thoracic Diseases."},{"issue":"1","key":"10.1002\/14651858.CD003900-BIB0040|cit40","first-page":"52","article-title":"Inhaled antimuscarinic agents and COPD","volume":"51","author":"Nardini","year":"1996","journal-title":"Monaldi Archives for Chest Disease"},{"issue":"4 Pt 1","key":"10.1002\/14651858.CD003900-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1164\/ajrccm.154.4.8887578","article-title":"Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma","volume":"154","author":"O'Connor","year":"1996","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD003900-BIB0042|cit42","first-page":"135","article-title":"Bronchodilators in the therapy of chronic obstructive pulmonary disease","volume":"3","author":"Rees","year":"1998","journal-title":"European Respiratory Monograph"},{"issue":"1","key":"10.1002\/14651858.CD003900-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1378\/chest.110.1.62","article-title":"Extended therapy with ipratropium is associated with improved lung function in patients with COPD: A retrospective analysis of data from seven clinical trials","volume":"110","author":"Rennard","year":"1996","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003900-BIB0044|cit44","first-page":"S11","article-title":"Choice of bronchodilator therapy in chronic obstructive pulmonary disease","volume":"2","author":"Rennard","year":"1997","journal-title":"Respirology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003900-BIB0045|cit45","first-page":"34","article-title":"The outpatient and hospital use of anticholinergics in COPD","volume":"33","author":"Sabradillo","year":"1997","journal-title":"Archivos De Bronconeumologia"},{"issue":"3","key":"10.1002\/14651858.CD003900-BIB0046|cit46","first-page":"389","article-title":"Effect of additional high dose inhalation of oxitropium bromide on respiratory function in the patients with COPD","volume":"18","author":"Sawa","year":"1997","journal-title":"Therapeutic Research"},{"issue":"5","key":"10.1002\/14651858.CD003900-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s002280050126","article-title":"Antimuscarinic effect of tiquizium bromide in vitro and in vivo","volume":"50","author":"Shioya","year":"1996","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003900-BIB0048|cit48","unstructured":"Tashkin D Celli B Decramer M Pauwels R Menjoge S Burkhart D Bronchodilator responsiveness in COPD patients enrolled in the UPLIFT trial [Abstract] American Thoracic Society 2005 International Conference; May 20-25; San Diego, California 2005 Poster J102"},{"issue":"1","key":"10.1002\/14651858.CD003900-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1183\/09031936.96.09010100","article-title":"Comparison of nebulized glycopyrrolate and metaproterenol in chronic obstructive pulmonary disease","volume":"9","author":"Tzelepis","year":"1996","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD003900-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"5 (Pt 2)","key":"10.1002\/14651858.CD003900-BIB0051|cit51","first-page":"S77","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease","volume":"152","author":"American Thoracic Society","year":"1995","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003900-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD003900-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1164\/ajrccm\/146.4.1067","article-title":"Bacterial infection in chronic obstructive pulmonary disease","volume":"146","author":"Murphy","year":"1992","journal-title":"American Review of Respiratory Disease"},{"issue":"8","key":"10.1002\/14651858.CD003900-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1183\/09031936.95.08081398","article-title":"Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force","volume":"8","author":"Siafakas","year":"1995","journal-title":"European Respiratory Journal"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003900\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T11:13:46Z","timestamp":1673435626000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003900"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2003,1,20]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003900","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,20]]}}}